Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 12.42M $69.92M Dec. 31, 2013
Partner Fund Management 5.05M $28.42M Dec. 31, 2013
FIRST MANHATTAN 4.96M $27.93M Dec. 31, 2013
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
STATE STREET CORPORATION 4.18M $23.51M Dec. 31, 2013
BlackRock Fund Advisors 3.91M $22.01M Dec. 31, 2013
Bank of America Corporation 3.70M $20.83M Dec. 31, 2013
FMR 3.09M $17.38M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 2.83M $15.94M Dec. 31, 2013
Vanguard 2.77M $15.62M Dec. 31, 2013
Millennium Management 2.66M $14.99M Dec. 31, 2013
Franklin Resources 2.32M $13.09M Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 2.24M $12.61M Dec. 31, 2013
Meditor 2.10M $12.87M Sept. 30, 2013
QVT Financial 1.99M $7.35M March 31, 2012
NEA Management Company 1.94M $10.90M Dec. 31, 2013
RS INVESTMENT MANAGEMENT 1.93M $10.87M Dec. 31, 2013
Visium Asset Management 1.67M $9.77M June 30, 2013
Farallon Capital Management 1.60M $9.04M Dec. 31, 2013
D. E. Shaw & Co 1.55M $8.72M Dec. 31, 2013
NORTHERN TRUST 1.51M $8.50M Dec. 31, 2013
FIL 1.51M $8.48M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 1.47M $8.30M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.41M $7.92M Dec. 31, 2013
Diamondback Capital Management 1.38M $7.63M June 30, 2012
CITADEL ADVISORS 1.35M $8.26M Sept. 30, 2013
FRED ALGER MANAGEMENT 1.29M $8.05M March 31, 2013
Redmile 1.19M $6.95M June 30, 2013
Columbus Circle Investors 1.06M $6.51M Sept. 30, 2013
Hudson Bay Capital Management 1.00M $5.64M Dec. 31, 2013
Apex Capital 1000000 $5.63M Dec. 31, 2013
CR Intrinsic Investors 954604 $5.58M June 30, 2013
Charles Schwab Investment Management 954600 $5.08M June 30, 2012
Adage Capital Partners GP 876000 $5.12M June 30, 2013
T. Rowe Price Associates 865700 $5.06M June 30, 2013
Jennison Associates 835590 $5.13M Sept. 30, 2013
I.G. Investment Management 826000 $4.65M Dec. 31, 2013
Timberline Asset Management 818575 $4.78M June 30, 2013
Teachers Advisors 781743 $4.80M Sept. 30, 2013
Oxford Asset Management 765559 $3.14M March 31, 2012
Name Passport Capital 750000 $3.94M Dec. 31, 2012

Who sold Orexigen Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Renaissance Technologies Sept. 30, 2011 786500 $1.57M
Daniel D. Thurber Dec. 31, 2010 1.95M $15.79M
BAM Capital Dec. 31, 2010 948131 $7.66M
Barclays Dec. 31, 2010 875700 $7.08M
Principal Financial Dec. 31, 2010 856110 $6.92M
Bridger Management Dec. 31, 2010 775000 $6.26M